BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2981419)

  • 1. Epithelial ovarian carcinoma of low malignant potential.
    Barnhill D; Heller P; Brzozowski P; Advani H; Gallup D; Park R
    Obstet Gynecol; 1985 Jan; 65(1):53-9. PubMed ID: 2981419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival among women with borderline ovarian tumors and ovarian carcinoma: a population-based analysis.
    Sherman ME; Mink PJ; Curtis R; Cote TR; Brooks S; Hartge P; Devesa S
    Cancer; 2004 Mar; 100(5):1045-52. PubMed ID: 14983501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of radiotherapy for state I ovarian carcinoma].
    Sheng X; Sun J; Zhou C
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):314-6. PubMed ID: 9387332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment and prognostic factors of epithelial ovarian carcinoma].
    Wang SL
    Zhonghua Fu Chan Ke Za Zhi; 1991 Mar; 26(2):86-8, 124. PubMed ID: 1650311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors in stage I ovarian carcinoma.
    Vergote I
    Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial ovarian tumors in the reproductive age group: age is not an independent prognostic factor.
    Massi D; Susini T; Savino L; Boddi V; Amunni G; Colafranceschi M
    Cancer; 1996 Mar; 77(6):1131-6. PubMed ID: 8635134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on malignant ovarian tumor--with special reference to therapy and prognosis of epithelial ovarian tumor].
    Iwasawa H; Sekiya S; Kaihou T; Takamizawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Apr; 36(4):525-30. PubMed ID: 6325559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial ovarian tumors of low malignant potential.
    Massad LS; Hunter VJ; Szpak CA; Clarke-Pearson DL; Creasman WT
    Obstet Gynecol; 1991 Dec; 78(6):1027-32. PubMed ID: 1945202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival analysis in advanced epithelial ovarian carcinoma in relation to proliferative index of MIB-1 immunostaining.
    Kritpracha K; Hanprasertpong J; Chandeying V; Dechsukhum C; Geater A
    J Obstet Gynaecol Res; 2005 Jun; 31(3):268-76. PubMed ID: 15916666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Borderline and invasive epithelial ovarian tumors in young women.
    Carter J; Fowler J; Carlson J; Carson L; Twiggs LB
    Obstet Gynecol; 1993 Nov; 82(5):752-6. PubMed ID: 8414321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An assessment of pathologic features and treatment modalities in ovarian tumors of low malignant potential.
    Hopkins MP; Kumar NB; Morley GW
    Obstet Gynecol; 1987 Dec; 70(6):923-9. PubMed ID: 3684131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epithelial ovarian tumors in adolescence: a study of clinical features and treatment].
    Li M; Pan LY; Huang HF; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2004 Sep; 39(9):598-601. PubMed ID: 15498186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinically apparent early stage invasive epithelial ovarian carcinoma: should all be treated similarly?
    Le T; Krepart GV; Lotocki RJ; Heywood MS
    Gynecol Oncol; 1999 Aug; 74(2):252-4. PubMed ID: 10419740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial ovarian cancer: impact of surgery and chemotherapy on survival during 1977-1990.
    Venesmaa P
    Obstet Gynecol; 1994 Jul; 84(1):8-11. PubMed ID: 8008329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective cohort study of surgical staging for ovarian low malignant potential tumors.
    Wingo SN; Knowles LM; Carrick KS; Miller DS; Schorge JO
    Am J Obstet Gynecol; 2006 May; 194(5):e20-2. PubMed ID: 16647891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaplastic carcinoma in mucinous ovarian tumors: a clinicopathologic study of 34 cases emphasizing the crucial impact of stage on prognosis, their histologic spectrum, and overlap with sarcomalike mural nodules.
    Provenza C; Young RH; Prat J
    Am J Surg Pathol; 2008 Mar; 32(3):383-9. PubMed ID: 18300813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic importance of intraoperative rupture of malignant ovarian epithelial neoplasms.
    Sainz de la Cuesta R; Goff BA; Fuller AF; Nikrui N; Eichhorn JH; Rice LW
    Obstet Gynecol; 1994 Jul; 84(1):1-7. PubMed ID: 8008300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.